Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17414462rdf:typepubmed:Citationlld:pubmed
pubmed-article:17414462lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0002475lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C1550147lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C1514923lld:lifeskim
pubmed-article:17414462lifeskim:mentionsumls-concept:C1285530lld:lifeskim
pubmed-article:17414462pubmed:issue2lld:pubmed
pubmed-article:17414462pubmed:dateCreated2007-4-6lld:pubmed
pubmed-article:17414462pubmed:abstractTextThe aim of this retrospective study was to evaluate the activity and toxicity of a combined chemotherapy containing mitomycin, folinate, and 5-fluorouracil (MiFoFU) in patients with advanced metastatic breast cancer and reduced performance status, ie, elderly patients or heavily pretreated patients.lld:pubmed
pubmed-article:17414462pubmed:languageenglld:pubmed
pubmed-article:17414462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17414462pubmed:citationSubsetIMlld:pubmed
pubmed-article:17414462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17414462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17414462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17414462pubmed:statusMEDLINElld:pubmed
pubmed-article:17414462pubmed:monthAprlld:pubmed
pubmed-article:17414462pubmed:issn1537-453Xlld:pubmed
pubmed-article:17414462pubmed:authorpubmed-author:SchneeweissAn...lld:pubmed
pubmed-article:17414462pubmed:authorpubmed-author:BrucknerThoma...lld:pubmed
pubmed-article:17414462pubmed:authorpubmed-author:SohnChristofClld:pubmed
pubmed-article:17414462pubmed:authorpubmed-author:EichbaumMicha...lld:pubmed
pubmed-article:17414462pubmed:authorpubmed-author:GastAnne-Sybi...lld:pubmed
pubmed-article:17414462pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17414462pubmed:volume30lld:pubmed
pubmed-article:17414462pubmed:ownerNLMlld:pubmed
pubmed-article:17414462pubmed:authorsCompleteYlld:pubmed
pubmed-article:17414462pubmed:pagination139-45lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:meshHeadingpubmed-meshheading:17414462...lld:pubmed
pubmed-article:17414462pubmed:year2007lld:pubmed
pubmed-article:17414462pubmed:articleTitleActivity and tolerability of a combined palliative chemotherapy with mitomycin C, folinate, and 5-Fluorouracil in patients with advanced breast cancer after intensive pretreatment: a retrospective analysis.lld:pubmed
pubmed-article:17414462pubmed:affiliationDepartment of Gynecology and Obstetrics, University of Heidelberg Medical School, Heidelberg, Germany. Michael_Eichbaum@med.uni-heidelberg.delld:pubmed
pubmed-article:17414462pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17414462lld:pubmed